Andrew Lo - Insider Trading & Ownership

Location
C/O Alphasimplex Group, Llc, One Cambridge Center, 9 Th Floor, Cambridge, MA
Summary
The estimated net worth of Andrew Lo is at least $8.07M dollars as of June 24, 2025. Andrew Lo is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $5.59M. Andrew Lo is the Director of AbCellera Biologics Inc. and owns shares of AbCellera Biologics Inc. (ABCL) stock worth about $1.94M. Andrew Lo is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $540K.
Signature
/s/ Andrew W. Lo, Ph.D.
All Insider Reports
All Insider Reports

Ownership of Andrew Lo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. Director $5.59M -$3.85M -40.8% Jun 20, 2025
ABCL AbCellera Biologics Inc. Director $1.94M Jun 12, 2025
ROIV Roivant Sciences Ltd. Director $540K Sep 15, 2022

Insider Transactions Reported by Andrew Lo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.